Human immunodeficiency virus, type 2 [HIV-2] infection in conditions classified elsewhere and of unspecified site
|
0.030 |
Biomarker
|
disease |
BEFREE |
Using a specific monoclonal antibody, we showed here that gp80 is a dimeric form of the transmembrane glycoprotein gp36 of HIV-2.
|
2296088 |
1990 |
Jaw Keratocyst
|
0.030 |
Biomarker
|
disease |
BEFREE |
We have identified strong expression of a 38-kD cell surface glycoprotein (gp38), a marker of basal cell carcinomas (BCCs), in basal and suprabasal epithelial cell membranes of parakeratinised odontogenic keratocysts.
|
7506776 |
1993 |
Carcinoma, Basal Cell
|
0.020 |
Biomarker
|
disease |
BEFREE |
We have identified strong expression of a 38-kD cell surface glycoprotein (gp38), a marker of basal cell carcinomas (BCCs), in basal and suprabasal epithelial cell membranes of parakeratinised odontogenic keratocysts.
|
7506776 |
1993 |
Malignant neoplasm of ovary
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
The glycoprotein gp38 is overexpressed in 90% of ovarian carcinomas and recognized by monoclonal antibodies MOv18 and MOv19.
|
8242637 |
1993 |
Pneumonia, Bacterial
|
0.200 |
Biomarker
|
group |
RGD |
A type I cell-specific protein is a biochemical marker of epithelial injury in a rat model of pneumonia.
|
7864138 |
1995 |
Nephrosis
|
0.200 |
Biomarker
|
disease |
RGD |
Podoplanin, novel 43-kd membrane protein of glomerular epithelial cells, is down-regulated in puromycin nephrosis.
|
9327748 |
1997 |
Neoplasms
|
0.100 |
AlteredExpression
|
group |
BEFREE |
Podoplanin expression in primary KS tumor lysates was confirmed by Western blot analysis.
|
10068212 |
1999 |
Kaposi Sarcoma
|
0.020 |
AlteredExpression
|
disease |
BEFREE |
In contrast to KS tumor cells in situ, no expression of VEGFR-3 and podoplanin was detected in any of four KS-derived spindle cell cultures and in one KS-derived autonomously growing cell line (KS Y-1).
|
10068212 |
1999 |
Tumor Cell Invasion
|
0.100 |
Biomarker
|
phenotype |
BEFREE |
In this study we have shown that gp40, a mucin-like glycoprotein, is localized to the surface and apical region of invasive stages of the parasite and is shed from its surface. gp40-specific antibodies neutralize infection in vitro, and native gp40 binds specifically to host cells, implicating this glycoprotein in C. parvum attachment to and invasion of host cells.
|
10858228 |
2000 |
Cryptosporidiosis
|
0.010 |
Biomarker
|
disease |
BEFREE |
The surface localization of gp40 and gp15 and their involvement in the host-parasite interaction suggest that either or both of these glycoproteins may serve as effective targets for specific preventive or therapeutic measures for cryptosporidiosis.
|
10858228 |
2000 |
Human immunodeficiency virus, type 2 [HIV-2] infection in conditions classified elsewhere and of unspecified site
|
0.030 |
Biomarker
|
disease |
BEFREE |
This ELISA, using a specific immunodominant epitope (11 amino acids) from the transmembrane (gp36) portion of the HIV-2 envelope glycoprotein showed a high concordance with PCR findings.
|
11418351 |
2001 |
Respiratory Distress Syndrome, Adult
|
0.210 |
Biomarker
|
disease |
RGD |
Low tidal volume reduces epithelial and endothelial injury in acid-injured rat lungs.
|
11790662 |
2002 |
Oligohydramnios
|
0.200 |
Biomarker
|
phenotype |
RGD |
Effects of oligohydramnios on lung growth and maturation in the fetal rat.
|
11839536 |
2002 |
Tumor Cell Invasion
|
0.100 |
Biomarker
|
phenotype |
BEFREE |
This gene encodes a precursor protein that is proteolytically cleaved to yield mature cell surface glycoproteins gp40 and gp15, which are implicated in zoite attachment to and invasion of enterocytes.
|
12065532 |
2002 |
Hyperoxia
|
0.200 |
Biomarker
|
phenotype |
RGD |
Protein nitration in rat lungs during hyperoxia exposure: a possible role of myeloperoxidase.
|
12922978 |
2003 |
Malignant Neoplasms
|
0.100 |
AlteredExpression
|
group |
BEFREE |
Podoplanin expression was also increased in the cancer samples.
|
12851706 |
2003 |
Primary malignant neoplasm
|
0.100 |
AlteredExpression
|
group |
BEFREE |
Podoplanin expression was also increased in the cancer samples.
|
12851706 |
2003 |
Hemangioma
|
0.020 |
Biomarker
|
disease |
BEFREE |
By contrast, blood vessel endothelium and hemangiomas were strongly positive for PAL-E and CD34 but were mostly negative for CD9 and podoplanin.
|
14559986 |
2003 |
Neoplasms, Vascular Tissue
|
0.020 |
AlteredExpression
|
group |
BEFREE |
Using immunohistochemistry, expression of CD9 was studied in 17 samples of head and neck mucosa and skin (laryngeal mucosa: n = 2, oral: n = 6, and epidermis: n = 9) and a variety of vascular tumors (lymphangiomas: n = 9, juvenile nasopharyngeal angiofibromas: n = 4, hemangiomas: n = 7, angiosarcomas: n = 5, and Kaposi's sarcomas: n = 7) and compared with the expression of CD34 and PAL-E (blood vessel markers) and the lymphatic marker podoplanin.
|
14559986 |
2003 |
Kaposi Sarcoma
|
0.020 |
AlteredExpression
|
disease |
BEFREE |
Using immunohistochemistry, expression of CD9 was studied in 17 samples of head and neck mucosa and skin (laryngeal mucosa: n = 2, oral: n = 6, and epidermis: n = 9) and a variety of vascular tumors (lymphangiomas: n = 9, juvenile nasopharyngeal angiofibromas: n = 4, hemangiomas: n = 7, angiosarcomas: n = 5, and Kaposi's sarcomas: n = 7) and compared with the expression of CD34 and PAL-E (blood vessel markers) and the lymphatic marker podoplanin.
|
14559986 |
2003 |
Colorectal Neoplasms
|
0.010 |
AlteredExpression
|
group |
LHGDN |
Molecular identification of Aggrus/T1alpha as a platelet aggregation-inducing factor expressed in colorectal tumors.
|
14522983 |
2003 |
Lymphangioma
|
0.010 |
Biomarker
|
disease |
BEFREE |
Regular lymphatic endothelium and lymphangiomas were strongly positive for CD9 and podoplanin but were mostly negative for PAL-E and CD34.
|
14559986 |
2003 |
Hepatitis C
|
0.010 |
Biomarker
|
disease |
BEFREE |
The arrays permitted the simultaneous serodetection of antibodies directed against hepatitis C virus (HCV core p21 15-45 peptide, NS4 1925-1947 peptide, core, NS3, NS4, and mixture of core, NS3, NS4, and NS5 antigens), hepatitis B virus (HBc, HBe, and HBs), human immunodeficiency virus (Gp41 and Gp120 for HIV-I and Gp36 for HIV-II), Epstein-Barr virus (VCAp18 153-176 peptide), and syphilis (rTpN47 and rTpN17) antigens using an immunofluorescence assay.
|
15025526 |
2004 |
Syphilis
|
0.010 |
Biomarker
|
disease |
BEFREE |
The arrays permitted the simultaneous serodetection of antibodies directed against hepatitis C virus (HCV core p21 15-45 peptide, NS4 1925-1947 peptide, core, NS3, NS4, and mixture of core, NS3, NS4, and NS5 antigens), hepatitis B virus (HBc, HBe, and HBs), human immunodeficiency virus (Gp41 and Gp120 for HIV-I and Gp36 for HIV-II), Epstein-Barr virus (VCAp18 153-176 peptide), and syphilis (rTpN47 and rTpN17) antigens using an immunofluorescence assay.
|
15025526 |
2004 |
Inflammation
|
0.200 |
Biomarker
|
phenotype |
RGD |
Coexpression of RTI40 with alveolar epithelial type II cell proteins in lungs following injury: identification of alveolar intermediate cell types.
|
15849211 |
2005 |